Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • They remember fishing in the lake. [undo]
  • Salbutamol (SABA) [undo]
  • Costas and his father discuss at the park. [undo]
  • Pioglitazone [undo]
  • Decision: Initial Approach [undo]
  • Κλινική εξέταση [undo]
  • Amnestic exam [undo]
  • Ο2 & iv υγρά & σαλβουταμόλη. και αέρια αίματος [undo]
  • Use open-ended questions and clarify priority symptoms (pain, discharge, fever). [undo]
  • Ο2 & iv υγρά & σαλβουταμόλη. [undo]
  • Presentation [undo]
  • Grapefruit-thiazide diuretic interaction [undo]
  • Increased entry of fatty acids into adipocytes [undo]
  • Decreased entry of glucose into muscle cells [undo]
  • Εργαστηριακά 2 [undo]
  • Guanethidine [undo]
  • I will independently adjust the dose of warfarin (decrease/increase)This is a wrong response that could lead to potentially harmful results to the health [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21091
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway